Found 8 matching trials
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia
PHASE2This is a Phase 2a, multicenter, randomized, double-blind, placebo-controll...
Location
Paratus - Canberra Clinic
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
PHASE1The purpose of this study is to assess the safety, tolerability, pharmacoki...
Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects
PHASE1This is a single center, open-label, single-dose, 2-way randomized crossove...
Location
Pharmaron CPC, Inc.
Drug-Drug Interaction Study of ABP-671 in Gout Patients
PHASE1This is a open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671...
Location
Wakefield Clinical Research
Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
PHASE2This is a multicenter, randomized, double-blind, Phase 2b/3 study to evalua...
Location
Alliance for Multispecialty Research
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
PHASE2This is a phase 2, international, multicenter, randomized, double blind, pl...
Location
Renal Research Gosford Pty Ltd
Extension Study of ABP-671 in Participants With Gout
PHASE2The primary objectives of this study are to assess the safety, tolerability...
Location
Alliance for Multispecialty Research
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
PHASE1The purpose of this study is to assess the safety, tolerability, pharmacoki...